Market Research

Ischemic Stroke Market Size - By Diagnosis, By Drug Class, By Surgery, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

Best Price Guarantee Length Publisher Published Date SKU
from $4,250 248 Pages SPER Market Research Pvt. Ltd. December, 2022 SPER18001327
Best Price Guarantee
Price from $4,250
Length 248 Pages
Publisher SPER Market Research Pvt. Ltd.
Published Date December, 2022
SKU SPER18001327

Ischemic Stroke Market Size - By Diagnosis, By Drug Class, By Surgery, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2032


Global Ischemic Stroke Market Overview:

According to SPER Market Research, the Global Ischemic Stroke Market is estimated to reach USD 13.54 billion by 2032 with a CAGR of 4.24%. Strokes can also happen when the blood supply to the brain is cut off. Strokes frequently happen when a blood vessel in the brain rupture, allowing haemorrhage to escape. This fracture, or any other sort of obstruction, prevented the blood and oxygen from reaching the brain tissues. Transient ischemic attack (TIA), haemorrhagic stroke, or ischemic stroke are the three main types of strokes that affect everyone in the globe.

Impact of COVID-19 on the Global Ischemic Stroke Market

According to the Ischemic Stroke market analysis, the virus known as the severity of acute respiratory syndrome of coronavirus 2 that is spread within people is the cause of this condition. Additionally, there has been a slight decline in hospital sectors as a result of the COVID-19 pandemic. It was as a result of individuals becoming afraid of the infection during the lockdown and distance-keeping phase. For health emergencies, a number of nations imposed a rigorous lockdown on their territory.

Scope of the Report:

Market size available for years 2019-2032
Base year considered 2021
Forecast period 2022-2032

Segments covered By Diagnosis, By Drug Class, By Surgery, By End User

Regions covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered Abott Laboratories, Bayer AG, Boehringer Ingelheim, Boston Scientific Corporation, Cordis Corporation, Covidien plc, GE Healthcare, Genentech, Inc.

Global Ischemic Stroke Market Segmentation:

By Surgery:Based on the Surgery, Global Ischemic Stroke Market is segmented as; Angioplasty, Carotid Endarterectomy, Endovascular Mechanical Thrombectomy.

By End User:Based on the End User, Global Ischemic StrokeMarket is segmented as; Hospitals & Clinic, Medical Institutes, Research Organization, Others.

By Region:Due to rapid technological improvement in the acute ischemic stroke treatment process and supportive government policies, the North American area dominates the acute ischemic stroke diagnosis and treatment market.


1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2. COVID-19 Impacts of the Global Ischemic Stroke Market
5. Market variables and outlook
5.1. SWOT analysis
5.1.1 Strengths
5.1.2 Weaknesses
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape
5.2.4 Technological landscape
5.2.5 Environmental landscape
5.2.6 Legal landscape
5.3. PORTER’S five forces analysis
5.3.1 Bargaining power of suppliers
5.3.2 Bargaining power of Buyers
5.3.3 Threat of Substitute
5.3.4 Threat of new entrant
5.3.5 Competitive rivalry
5.4. Heat map analysis
6. Global Ischemic Stroke Market, By Diagnosis, 2019-2032 (USD Million)
6.1. Carotid Ultrasound
6.2. Cerebral Ultrasound
6.3. Compound Angiography
6.4. Echocardiography
6.5. Electrocardiography
6.6. Magnetic Resonance Imaging
6.7. Others
7. Global Ischemic Stroke Market, By Drug Class, 2019-2032 (USD Million)
7.1. Tissue Plasminogen Activator
7.2. Anticoagulant
7.3. Antiplatelet
7.4. Antihypertensive
7.5. Others
8. Global Ischemic Stroke Market, By Surgery, 2019-2032 (USD Million)
8.1. Angioplasty
8.2. Carotid Endarterectomy
8.3. Endovascular Mechanical Thrombectomy
9. Global Ischemic Stroke Market, By End User, 2019-2032 (USD Million)
9.1. Hospitals & Clinic
9.2. Medical Institutes
9.3. Research Organization
9.4. Others
10. Global Ischemic Stroke Market, By Region, 2019-2032 (USD Million)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. Europe
10.2.1. Germany
10.2.2. United Kingdom
10.2.3. France
10.2.4. Italy
10.2.5. Spain
10.2.6. Rest of Europe
10.3. Asia-Pacific
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia
10.3.5. South Korea
10.3.6. Rest of Asia-Pacific
10.4. South America
10.4.1. Brazil
10.4.2. Argentina
10.4.3. Rest of South America
10.5. Middle East & Africa
10.5.1. Kingdom of Saudi Arabia
10.5.2. United Arab Emirates
10.5.3. Rest of Middle East & Africa
11. Company Profiles
11.1. Abott Laboratories
11.1.1. Company details
11.1.2. Financial outlook
11.1.3. Product summary
11.1.4. Recent developments
11.2. Bayer AG
11.2.1. Company details
11.2.2. Financial outlook
11.2.3. Product summary
11.2.4. Recent developments
11.3. Boehringer Ingelheim
11.3.1. Company details
11.3.2. Financial outlook
11.3.3. Product summary
11.3.4. Recent developments
11.4. Boston Scientific Corporation
11.4.1. Company details
11.4.2. Financial outlook
11.4.3. Product summary
11.4.4. Recent developments
11.5. Cordis Corporation
11.5.1. Company details
11.5.2. Financial outlook
11.5.3. Product summary
11.5.4. Recent developments
11.6. Covidien plc
11.6.1. Company details
11.6.2. Financial outlook
11.6.3. Product summary
11.6.4. Recent developments
11.7. GE Healthcare
11.7.1. Company details
11.7.2. Financial outlook
11.7.3. Product summary
11.7.4. Recent developments
11.8. Genentech, Inc.
11.8.1. Company details
11.8.2. Financial outlook
11.8.3. Product summary
11.8.4. Recent developments
11.9. Jhonson&Jhonson
11.9.1. Company details
11.9.2. Financial outlook
11.9.3. Product summary
11.9.4. Recent developments
11.10. Koninklijke Philips N.V.
11.10.1. Company details
11.10.2. Financial outlook
11.10.3. Product summary
11.10.4. Recent developments
11.11. Medtronic plc
11.11.1. Company details
11.11.2. Financial outlook
11.11.3. Product summary
11.11.4. Recent developments
11.12. Merck & Co. Inc.
11.12.1. Company details
11.12.2. Financial outlook
11.12.3. Product summary
11.12.4. Recent developments
11.13. Philips Healthcare
11.13.1. Company details
11.13.2. Financial outlook
11.13.3. Product summary
11.13.4. Recent developments
11.14. Sanofi
11.14.1. Company details
11.14.2. Financial outlook
11.14.3. Product summary
11.14.4. Recent developments
11.15. Stryker Corporation
11.15.1. Company details
11.15.2. Financial outlook
11.15.3. Product summary
11.15.4. Recent developments

$4,250
$7,450

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings